AusperBio Highlights Major Advances in AHB-137 Clinical Development ...Middle East

PR Newswire - News
AusperBio Highlights Major Advances in AHB-137 Clinical Development
SAN FRANCISCO, July 5, 2024 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies, with the goal of achieving functional cure for chronic...

Hence then, the article about ausperbio highlights major advances in ahb 137 clinical development was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AusperBio Highlights Major Advances in AHB-137 Clinical Development )

Apple Storegoogle play

Last updated :

Also on site :